ICU admission |
5 (3.2%) |
0 |
5 (4.0%) |
.584 |
Complications |
|
|
|
|
ARDS |
1 (0.6%) |
0 |
1 (0.8%) |
1.000 |
Acute kidney injury |
1 (0.6%) |
0 |
1 (0.8%) |
1.000 |
Acute liver injury |
4 (2.6%) |
0 |
4 (3.2%) |
.584 |
Urinary tract infection |
2 (1.3%) |
1 (3.2%) |
1 (0.8%) |
.361 |
Treatments |
|
|
|
|
Antiviral therapy |
132 (85.2%) |
27 (87.1%) |
105 (84.7%) |
.955 |
Antibiotic therapy |
94 (60.6%) |
27 (87.1%) |
67 (54.0%) |
.001 |
Corticosteroid |
43 (27.7%) |
23 (74.2%) |
20 (16.1%) |
<.001 |
Immunoglobulin |
32 (20.6%) |
5 (16.1%) |
27 (21.8%) |
.487 |
Continuous renal replacement therapy |
1 (0.6%) |
0 |
1 (0.8%) |
1.000 |
Oxygen support |
56 (36.1%) |
22 (71.0%) |
34 (27.4%) |
<.001 |
Mask and Nasal cannula |
53 (34.2%) |
22 (71.0%) |
31 (25.0%) |
… |
Non-invasive ventilation or high-flow nasal cannula |
2 (1.3%) |
0 |
2
(1.6%) |
… |
Invasive mechanical ventilation |
0 |
0 |
0 |
… |
Invasive mechanical ventilation and ECMO |
1 (0.6%) |
0 |
1 (0.8%) |
… |
Clinical outcomes |
|
|
|
|
Hospital stays, days |
9 (8.0, 17.0) |
13 (9.0, 24.0) |
9.0 (8.0, 15.8) |
.062 |
Discharge |
155 (100.0%) |
31 (100.0%) |
124 (100.0%) |
… |